Choice of Outcome Measure Predicts Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder [Letter]
Céline Wessa,1,2 Manuel Morrens,1,2 Livia J De Picker1,2 1Scientific Initiative for Neuropsychiatric and Psychopharmacological Studies (SINAPS), University Psychiatric Hospital Campus Duffel, Duffel, Belgium; 2Collaborative Antwerp Psychiatric Research Institute (CAPRI), Faculty of Medici...
Main Authors: | Wessa C, Morrens M, De Picker LJ |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-03-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/choice-of-outcome-measure-predicts-anti-inflammatory-treatment-efficac-peer-reviewed-fulltext-article-NDT |
Similar Items
-
Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder: A Systematic Review of Meta-Analyses
by: Simon MS, et al.
Published: (2023-01-01) -
Research progress of anti-inflammatory agents in the treatment of major depressive disorder
by: Du Yue, et al.
Published: (2023-08-01) -
Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: a novel dual outcome measure in depressive disorders
by: М. С. Christensen, et al.
Published: (2019-07-01) -
Telomere attrition and inflammatory load in major depressive disorder
by: A. Squassina
Published: (2021-04-01) -
Appropriate Outcome Choice Requires Certainty About Symptom Patterns of Patient Subgroups – We are Still Left with Unexplained Heterogeneity [Response To Letter]
by: Simon MS
Published: (2023-03-01)